Inhibitory mechanism of vortioxetine on CYP450 enzymes in human and rat liver microsomes.

CYP450 UPLC-MS/MS drug-drug interaction inhibition mechanism vortioxetine

Journal

Frontiers in pharmacology
ISSN: 1663-9812
Titre abrégé: Front Pharmacol
Pays: Switzerland
ID NLM: 101548923

Informations de publication

Date de publication:
2023
Historique:
received: 03 04 2023
accepted: 16 08 2023
medline: 4 10 2023
pubmed: 4 10 2023
entrez: 4 10 2023
Statut: epublish

Résumé

Vortioxetine is a novel anti-major depression disorder drug with a high safety profile compared with other similar drugs. However, little research has been done on drug-drug interactions (DDI) about vortioxetine. In this paper, the inhibitory effect of vortioxetine on cytochrome P450 (CYP450) and the type of inhibitory mechanism were investigated in human and rat liver microsomes. We set up an

Identifiants

pubmed: 37790811
doi: 10.3389/fphar.2023.1199548
pii: 1199548
pmc: PMC10544575
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1199548

Informations de copyright

Copyright © 2023 Zhan, Wang, Yu, Chen, Xu, Nie and Lin.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Drug Metab Dispos. 2012 Jul;40(7):1357-65
pubmed: 22496396
J Pharm Sci. 2008 May;97(5):1775-800
pubmed: 17853429
Can J Psychiatry. 2014 Dec;59(12):649-54
pubmed: 25702365
Ther Adv Psychopharmacol. 2021 Sep 3;11:20451253211034320
pubmed: 34497709
Eur J Drug Metab Pharmacokinet. 2019 Oct;44(5):611-618
pubmed: 30825074
Drug Metab Dispos. 2009 Jul;37(7):1355-70
pubmed: 19359406
Toxicol Lett. 2015 Nov 19;239(1):1-8
pubmed: 26278343
AAPS J. 2008 Jun;10(2):410-24
pubmed: 18686042
Toxicol Lett. 2018 Nov;297:1-7
pubmed: 30138636
J Biol Chem. 2015 May 22;290(21):13128-43
pubmed: 25855791
CNS Spectr. 2014 Apr;19(2):121-33
pubmed: 23903233
Arch Toxicol. 1997;71(6):401-8
pubmed: 9195021
Pharmacol Rep. 2020 Dec;72(6):1685-1694
pubmed: 32279279
J Biol Chem. 2015 Feb 6;290(6):3248-68
pubmed: 25533464
Adv Ther. 2019 Nov;36(11):3134-3146
pubmed: 31552551
Drugs. 2016 Nov;76(17):1675-1682
pubmed: 27807822
Curr Drug Targets. 2018;19(12):1412-1423
pubmed: 29149828
Xenobiotica. 2015;45(7):571-7
pubmed: 25811791
Pharmacol Rep. 2020 Jun;72(3):612-621
pubmed: 32219694
Clin Pharmacokinet. 2018 Jun;57(6):673-686
pubmed: 29189941
J Phys Chem B. 2020 Sep 24;124(38):8259-8265
pubmed: 32845149
Xenobiotica. 2013 Nov;43(11):948-55
pubmed: 23593983
Eur J Pharm Sci. 2016 Jun 10;88:70-82
pubmed: 27019345
Am J Gastroenterol. 2003 Dec;98(12):2616-20
pubmed: 14687806
Sci Rep. 2022 Dec 19;12(1):21889
pubmed: 36536002
Mol Pharmacol. 2020 Nov;98(5):529-539
pubmed: 32938720

Auteurs

Yunyun Zhan (Y)

Department of Pharmacy, The Affiliated Lihuili Hospital, Ningbo University, Ningbo, Zhejiang, China.

Anzhou Wang (A)

Department of Pharmacy, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Yige Yu (Y)

Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Jie Chen (J)

Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Xinhao Xu (X)

Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Jingjing Nie (J)

Department of Pharmacy, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Jingjing Lin (J)

Department of Pharmacy, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.

Classifications MeSH